Drug Database
Back to search

Netherlands· NL-abde5ebb82b5

Adenuric 80 mg, filmomhulde tabletten

A febuxostat product containing febuxostat, registered in Netherlands by Menarini International Operations Luxembourg S.A.. The same ATC class is registered in 19 of our 19 countries.

ATC M04AA03

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedAdenuric 80 mg, filmomhulde tablettenATCM04AA03REGISTER NO.NL-abde5ebb82b5PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about febuxostatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Febuxostat is registered in 19 of 19 countries.

Countries holding a registration under ATC M04AA03 (febuxostat), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 11 of them publish a price we can compare per daily dose
Search febuxostat products by name

Febuxostat · ATC M04AA03

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of febuxostat costs, country by country.

Normalised to the WHO defined daily dose (80 mg), the median price runs from $0.34 in France to $1.89 in Switzerland — a ×5.6 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Febuxostat · price per daily dose (80 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.89
  • IT Italy$0.69
  • ES Spain$0.54
  • FR France$0.34
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
FEBUXOSTAT
Manufacturer
Menarini International Operations Luxembourg S.A.
Country
Netherlands (NL)
ATC code
M04AA03
ATC class
Febuxostat
Defined daily dose
80 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/08/447

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

25 interactions on record for febuxostat.

Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check febuxostat against other medicinesHow interaction checks work

Febuxostat · interactions on record

25 records

  • 6 severe
  • 19 moderate

Most severe, free to view

  • MercaptopurineL01BB02severe
  • LeflunomidL04AA13severe
  • TeriflunomidL04AA31severe
  • LeflunomideL04AK01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Febuxostat in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All febuxostat products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Feburo, Febuxostat +pharma
  • Belgium · Feburik, Febuxostat Ab
  • Bulgaria · Адара, Адара 80 Mg Филмирани Таблетки
  • Cyprus · Febuxostat Genepharm, Urichofeb
  • Czechia · Febuxostat Sandoz
  • Germany · Febuxodor, Febuxostat 1 A Pharma
  • Denmark · Febuxostat Accord, Febuxostat Teva
  • Estonia · Druniler, Febuxostat Alembic
  • Spain · Febuxostat Aurovitas, Febuxostat Cinfa
  • Finland · Febuxostat Accord
  • France · Febuxostat Accord, Febuxostat Almus
  • United Kingdom (Northern Ireland) · Elstabya, Febuxostat
  • Greece · Buxodem, Febuxostat Genepharm
  • Croatia · Abuxar, Febuksostat
  • Hungary · Denofix, Doluric
  • Ireland · Febuxostat Clonmel, Febuxostat Rowa
  • Iceland · Adenuric, Febuxostat Krka
  • Italy · Alphabux, Arbux
  • Liechtenstein · Adenuric, Febuxostat Viatris
  • Lithuania · Druniler, Febuxostat Teva
  • Luxembourg · Feburik, Febuxostat
  • Latvia · Denofix, Druniler
  • Malta · Febuxostat Pharos
  • Norway · Adenuric, Febuxostat Krka
  • Poland · Denofix, Febuxostat Aurovitas
  • Portugal · Bluesar, Febuxostate Aristo
  • Sweden · Feburo
  • Slovenia · Abuxar
  • Slovakia · Febuxostat Sandoz

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1ac41dbe-c36d-4690-9f06-41da8daade7f
GET /v1/drugs/1ac41dbe-c36d-4690-9f06-41da8daade7f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/adenuric-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Febuxostat",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp73509",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "HYPROLOSE (E 463)",
    "IJZEROXIDE GEEL (E 172)",
    "LACTOSE 1-WATER",
    "MACROGOL 3350",
    "MAGNESIUMSTEARAAT (E 470b)",
    "POLYVINYLALCOHOL (E 1203)",
    "SILICIUMDIOXIDE, GEHYDRATEERD (E 551)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "FEBUXOSTAT"
  ],
  "leaflet_url": null,
  "authorised_at": "2008/04/21",
  "procedure_number": "EMEA/H/C/000777",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/08/447",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about febuxostat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console